The Second ECNP Summit on the future of CNS drug research in Europe
14 October 2012, Vienna, Austria
The Second ECNP Summit on the future of CNS drug research in Europe was held at the 25th ECNP Congress in Vienna, Austria.
For the Summit report, with a summary of the discussion and key outcomes, please click here.
To see the programme please click here.
The participants of the Second ECNP Summit were:
Celso Arango (ECNP)
Mary G. Baker (EBC)
David Baldwin (ECNP)
Alastair Benbow (EBC)
Richard Bergström (EFPIA)
Claire Bithell (SMC)
Patrice Boyer (EPA)
Wim van den Brink (ECNP)
Michael Davidson (ECNP)
Gerry Dawson (P1Vital)
Filippo Drago (EPHAR)
Dolores Gauci (GAMIAN-Europe)
Christine Gispen-de Wied (CBG)
Guy Goodwin (ECNP)
Michel Goldman (IMI)
Michel Hamon (ECNP)
Jaanus Harro (ECNP)
Paul Jenner (Novartis)
Shitij Kapur (NewMeds)
Gitte M. Knudsen (ECNP)
Marc Laruelle (UCB)
Thomas Lönngren (NDA Group)
Ruth McKernan (Neusentis)
Theo Meert (Janssen)
Mark Millan (ECNP)
Hans-Jürgen Möller (CINP)
David Nutt (ECNP)
Sven Ove Ögren (ECNP)
Anders G. Pedersen (Lundbeck)
Norman Sartorius (AIMHP)
Alexander Schubert (ECNP)
Eduard Vieta (ECNP)
Joseph Zohar (ECNP)
Apologies:
Philippe Cupers (DG Research)
Guido Rasi (EMA)
Related pages / downloads
Report
Programme